Aldeyra Therapeutics Inc (ALDX)
4.00
-0.07
(-1.72%)
USD |
NASDAQ |
May 09, 11:58
Aldeyra Therapeutics 1 Year Total Returns (Daily): -61.82% for May 8, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 08, 2024 | -61.82% |
| May 07, 2024 | -60.55% |
| May 06, 2024 | -61.02% |
| May 03, 2024 | -59.14% |
| May 02, 2024 | -58.64% |
| May 01, 2024 | -58.33% |
| April 30, 2024 | -58.66% |
| April 29, 2024 | -57.50% |
| April 26, 2024 | -56.67% |
| April 25, 2024 | -56.61% |
| April 24, 2024 | -58.31% |
| April 23, 2024 | -60.98% |
| April 22, 2024 | -60.78% |
| April 19, 2024 | -62.67% |
| April 18, 2024 | -62.06% |
| April 17, 2024 | -61.79% |
| April 16, 2024 | -62.93% |
| April 15, 2024 | -60.15% |
| April 12, 2024 | -57.37% |
| April 11, 2024 | -57.65% |
| April 10, 2024 | -58.86% |
| April 09, 2024 | -55.21% |
| April 08, 2024 | -55.71% |
| April 05, 2024 | -51.49% |
| April 04, 2024 | -52.77% |
| Date | Value |
|---|---|
| April 03, 2024 | -57.78% |
| April 02, 2024 | -64.25% |
| April 01, 2024 | -67.07% |
| March 28, 2024 | -64.26% |
| March 27, 2024 | -65.78% |
| March 26, 2024 | -67.66% |
| March 25, 2024 | -68.11% |
| March 22, 2024 | -64.02% |
| March 21, 2024 | -60.83% |
| March 20, 2024 | -60.75% |
| March 19, 2024 | -62.25% |
| March 18, 2024 | -63.18% |
| March 15, 2024 | -64.28% |
| March 14, 2024 | -64.76% |
| March 13, 2024 | -58.69% |
| March 12, 2024 | -58.15% |
| March 11, 2024 | -54.74% |
| March 08, 2024 | -50.88% |
| March 07, 2024 | -46.60% |
| March 06, 2024 | -46.60% |
| March 05, 2024 | -47.46% |
| March 04, 2024 | -45.59% |
| March 01, 2024 | -40.48% |
| February 29, 2024 | -46.45% |
| February 28, 2024 | -45.41% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-80.62%
Minimum
Mar 16 2020
622.8%
Maximum
Mar 16 2021
18.31%
Average
-20.91%
Median
Aug 29 2022
1 Year Total Returns (Daily) Benchmarks
| AbbVie Inc | 13.25% |
| United Therapeutics Corp | 24.06% |
| Heron Therapeutics Inc | 23.36% |
| Esperion Therapeutics Inc | 51.11% |
| FibroGen Inc | -93.64% |